Dianthus Therapeutics DNTH
NASDAQ DNTH
$108.10 +0.25 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Dianthus Therapeutics (DNTH) Property, Plant & Equipment (Net) (2017 - 2025)

Analysis

Dianthus Therapeutics (DNTH) Property, Plant & Equipment (Net) (2017 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Dianthus Therapeutics 4.09 Bn 3.69 Bn - 296,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 296,000.00
Sep 30, 2025 185,000.00
Jun 30, 2025 207,000.00
Mar 31, 2025 191,000.00
Dec 31, 2024 194,000.00
Sep 30, 2024 189,000.00
Jun 30, 2024 189,000.00
Mar 31, 2024 195,000.00
Dec 31, 2023 185,000.00
Sep 30, 2023 195,000.00
Dec 31, 2022 142,000.00
Sep 30, 2022 6.32 Mn
Jun 30, 2022 6.63 Mn
Mar 31, 2022 6.98 Mn
Dec 31, 2021 7.46 Mn
Sep 30, 2021 7.98 Mn
Jun 30, 2021 8.41 Mn
Mar 31, 2021 7.74 Mn
Dec 31, 2020 8.31 Mn
Sep 30, 2020 8.59 Mn